The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The 5-HT2A receptor antagonist M100,907 attenuates motor and ‘impulsive-type’ behaviours produced by NMDA receptor antagonism
Abstract
In the present series of studies, we have investigated the effects of antagonists selective for the 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors on motor and 'impulsive'-type behaviours elicited by the non-competitive N-methyl- d-aspartate (NMDA) antagonist dizocilpine. The selective 5-HT(2A) receptor antagonist M100,907 (0.5 mg/kg) attenuated the hyperlocomotion and stereotypy produced by dizocilpine (0.1-0.3 mg/kg). The selective 5-HT(2B) receptor antagonist SB215,505 (3 mg/kg) and the selective 5-HT(2C) receptor antagonist SB242,084 (0.5 mg/kg) had no effect against either measure, except that SB242,084 produced a small potentiation of the hyperactivity response. Dizocilpine (0.03 mg/kg) increased premature responding in rats performing the 5-choice serial reaction time task (5-CSRTT), and increased response frequency consequently reducing the mean inter-response time (IRT) and efficiency of responding in a DRL24 task. M100,907 (0.5 mg/kg) attenuated each of these effects, as well as the increased premature responding produced by the NMDA NR2B selective antagonist Ro 63-1908 (1 mg/kg) in the 5-CSRTT. In contrast SB242,084 (0.5 mg/kg) did not attenuate the dizocilpine-induced premature responding or increased responding in the DRL24 task. Rather, SB242,084 (0.05-0.5 mg/kg) produced qualitatively similar effects to dizocilpine, increasing premature responding and reducing IRT. The results suggest that 5-HT(2A) receptor antagonists may normalise certain 'impulsive' behaviours produced by NMDA receptor hypofunction. The 5-HT(2C) receptor antagonist SB242,084 failed to exert equivalent effects, rather a trend toward exacerbation of the behavioural changes produced by dizocilpine was apparent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In non-stressed animals both competitive NMDA-R antagonists, such as (R)-CPP (Mirjana et al 2004) and non-competitive NMDA-R antagonists such as dizocilpine, and phencyclidine (Higgins et al 2003, Le Pen et al 2003) injected into the mPFC produce pronounced attentional performance deficits as measured by increase in omissions and latency for correct detection in the 5-CSRTT.”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Higgins et al 2003
In the citing paper
“administration of the serotonin 5-HT2A receptor antagonist M100907 prevents increases in premature responding induced by MK-801 (Higgins et al 2003) and (R)-CPP (Ceglia et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Higgins et al 2003
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161 · cited 1×
“Over recent years, evidence has emerged of functional interactions between serotonergic 5-HT2A receptor systems (see Barnes and Sharp 1999, for review) and behaviours related to NMDA receptor blockade.”
BackgroundRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · cited 1×
“certain NMDA receptor antagonist-induced behaviours following 5-HT2A receptor antagonism are of interest, particularly given the evidence for NMDA receptor hypofunction as an underlying factor in the aetiology of schizophrenia ( Javitt and Zukin 1991; Breese et al. 2002), and evidence that 5-HT2A receptor antagonists…”
BackgroundThe 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282 · cited 1×
“For example, in behavioural situations requiring animals to tolerate a delay before making a response, such as performing the 5choice serial reaction time task (5-CSRTT; Robbins 2002 ) and operant responding maintained by a differential low rate of responding (DRL), dizocilpine pretreatment increases the probability o…”
BackgroundPompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881 · cited 1×
“In the CNS, the highest densities of 5-HT2A receptors are found in neocortex, particularly lamina II/III and V ( Pompeiano et al. 1994; Lopez-Gimenez et al. 1997; Jakab and Goldman-Rakic 1998), thus showing high overlap with NMDA NR2A and NR2B receptor subunits (Rudolf et al. 1996; Wenzel et al. 1997).”
BackgroundCarli, M., Robbins, T. W., Evenden, J. L., & Everitt, B. J. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90138-9 · Cited by 736
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · cited 1×
“In the CNS, the highest densities of 5-HT2A receptors are found in neocortex, particularly lamina II/III and V (Pompeiano et al. 1994; Lopez-Gimenez et al. 1997; Jakab and Goldman-Rakic 1998 ), thus showing high overlap with NMDA NR2A and NR2B receptor subunits (Rudolf et al. 1996; Wenzel et al. 1997).”
BackgroundSerotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 2×
“Thus, electrophysiological, biochemical and behavioural findings represent evidence for functional interactions between cortical 5-HT2A and glutamatergic NMDA systems ( Aghajanian and Marek 2000; Breese et al. 2002).”
BackgroundSB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
KENNETT, G. A., WOOD, M. D., BRIGHT, F., TRAIL, B., RILEY, G., HOLLAND, V., AVENELL, K. Y., STEAN, T., UPTON, N., BROMIDGE, S., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00038-5 · Cited by 523
Cited by
Neurobiology of Aggression and Violence
Siever, L. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111774 · Cited by 984
Winstanley, C. A., Eagle, D. M., & Robbins, T. W. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.01.001 · Cited by 842
The neuropharmacology of impulsive behaviour
PATTIJ, T., & VANDERSCHUREN, L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.002 · Cited by 473
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry
Dalley, J. W., Mar, A. C., Economidou, D., & Robbins, T. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.021 · Cited by 467
The neurobiology of aggression and violence
Rosell, D. R., & Siever, L. J. (2015) · CNS Spectrums · doi:10.1017/s109285291500019x · Cited by 440
Metadata
- Authors
- Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J.
- Affiliations
- F. Hoffmann-La Roche AG (CH)
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Higgins, Guy A.
- Venue
- Psychopharmacology
- Published
- 2003-08-07
- Volume
- 170
- Issue
- 3
- Pages
- 309-319
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1987351380
- Cited by
- 179
- References
- 65
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 11 · 2012: 15
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- F. Hoffmann-La Roche
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- 5-HT2A receptor, 5-HT2B receptor, 5-HT2C receptor, MK-801, NMDA receptor antagonism, impulsivity, premature responding, hyperlocomotion, stereotypy, NR2B, 5-choice serial reaction time task, delay discounting, serotonin antagonists
- MeSH terms
- Aminopyridines, Animals, Drug Interactions, Fluorobenzenes, Impulsive Behavior, Indoles, Male, Motor Activity, Piperidines, Reaction Time, Serotonin Antagonists, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Neuroprotective Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 5-HT2A receptor antagonist M100,907 attenuates motor and ‘impulsive-type’ behaviours produced by NMDA receptor antagonism. https://app.cochat.ai/papers/10.1007/s00213-003-1549-0
- The paper
- Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003). The 5-HT2A receptor antagonist M100,907 attenuates motor and ‘impulsive-type’ behaviours produced by NMDA receptor antagonism. Psychopharmacology. https://doi.org/10.1007/s00213-003-1549-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.